Skip to content

Clinical trials

Carcinoma, Non-Small-Cell Lung trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Country / region: China Clear all

1,674 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20033
20042
20054
200611
200714
200818
200928
201022
201127
201230
201339
201436
201548
201670
201772
201885
201996
2020121
2021134
2022145
2023141
2024185
2025193
2026146

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status484
Recruiting456
Completed345
Active, not recruiting184
Not yet recruiting109
Terminated65
Enrolling by invitation13
Withdrawn13
Suspended5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University91
AstraZeneca53
Hunan Province Tumor Hospital47
Fudan University43
Hoffmann-La Roche37
Tianjin Medical University Cancer Institute and Hospital37
Betta Pharmaceuticals Co., Ltd.35
Shanghai Pulmonary Hospital, Shanghai, China33
Shanghai Chest Hospital30
Guangdong Association of Clinical Trials26

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung1,674
Lung Neoplasms187
Colorectal Neoplasms53
Brain Neoplasms48
Neoplasms47
Breast Neoplasms36
Neoplasm Metastasis32
Squamous Cell Carcinoma of Head and Neck32
Melanoma31
Carcinoma30

Trials

Showing 51 to 75 of 1,674. Each trial links to its page on Pharma Observatory.

1,574 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.